NWPF

News ArchivesRead News

Ties between cholesterol and Parkinson’s in women

Thursday November 30, 2006

Nov 23, 2006 (Reuters) - Women with higher levels of total cholesterol appear to be at decreased risk for developing Parkinson’s disease, according to a report by researchers in the Netherlands.

Exactly why this association is not seen in men is unclear, but it may relate to a stronger association in women between levels of cholesterol and coenzyme Q10, an antioxidant that has shown promise against Parkinson’s disease in animal studies and clinical trials.

The findings are based on an analysis of data from the Rotterdam Study, including 2654 men and 3811 women at least 55 years of age. The average follow-up period was 9.4 years.

Dr. Monique M. B. Breteler, from Erasmus Medical Center and colleagues found that the risk of Parkinson’s disease fell by 23 percent for each mmol/L increase in the total cholesterol.

This association, which was confined to women, held true after adjusting for several possible confounders, the investigators report in the American Journal of Epidemiology.

Regarding the gender-based differences uncovered, previous reports have suggested that there is a stronger correlation between total cholesterol and coenzyme Q10 levels in women than in men. "On the other hand, lipid-modifying effects of estrogens have been reported that might account for the observed differences between men and women," the authors note.

"Our results call for further research on the relation among cholesterol, coenzyme Q10, and the risk of Parkinson’s disease," they add.

Recent News

Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show
Aug 14 - 16 Tips to Increase Your Mobility Confidence While Living With Parkinson’s Disease
Aug 10 - Boxers are fighting back against Parkinson’s
Aug 9 - Parkinson’s Experiment to Be Aboard Next Flight to International Space Station
Aug 9 - Parkinson’s Disease and Sleeping with the Enemy
Aug 7 - The Importance of Oral Health in Parkinson’s Disease
Aug 7 - Researchers Gain Better Insight Into Alpha-Synuclein’s Role in Parkinson’s Disease
Jul 31 - New Digital Cognitive Assessment Tool Receives Positive FDA Review
Jul 20 - Parkinson’s DREAM Challenge Uses Mobile Sensor Data to Monitor Health Based on Movement